Skip to content
New Resource: Psychedelics Drug Development Tracker
Psilocybin Alpha Logo Small
  • Home
  • Psychedelic Companies

      Psychedelic Sector Overview

      Psychedelic Sector Overview Mockup Small 3

      Explore the Psychedelic Sector Landscape visually using our new tool.

      Explore Now

      Company Profiles

      ATAI Life Sciences

      Beckley Psytech

      Better Plant Sciences

      CaaMTech

      Champignon Brands

      Compass Pathways

      Cybin Corp

      Eleusis

      Entheon Biomedical

      Field Trip

      Havn Life

      Hollister Biosciences

      MagicMed Industries

      MindMed

      Mydecine Innovations Group

      Numinus

      Revive Therapeutics

      Tryp Therapeutics

  • Watchlist
  • Data

      Psychedelics Patent Trackers

      We track the latest patents and filings related to psilocybin and MDMA.

      Psilocybin Patents
      Psilocybin Patent Filings
      MDMA Patents

      Psychedelics Drug Development Tracker

      From drug discovery to regulatory approval, we map drug development in psychedelics.

      Psychedelics Drug Development Tracker
  • News
      Weekly Psychedelic Bulletin

      News & Interviews

      Psychedelic Bulletin

      Psychedelics Research Review

  • Learn

      How to Buy Psychedelic Stocks

      Looking to invest in psychedelics? This handy guide explains how to buy stocks and shares outside of Canada.

      Read our Guide

      History & Context

      Future Prospects

      Institutional Interest

      How to Buy Psychedelic Stocks

      Psychedelics Glossary

  • Jobs
  • Contact
Search
Close

Novamind

Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF

Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF

  • Post published:February 22, 2021
  • Post category:Press Release
Novamind Announces Marketing Services Agreements

Novamind Announces Marketing Services Agreements

  • Post published:January 26, 2021
  • Post category:Press Release
Novamind Expands Psychedelic Medicine Access in Utah

Novamind Expands Psychedelic Medicine Access in Utah

  • Post published:January 13, 2021
  • Post category:Press Release
Novamind Completes Reverse Takeover Transaction

Novamind Completes Reverse Takeover Transaction

  • Post published:December 24, 2020
  • Post category:Press Release
Novamind Receives CSE Conditional Listing Approval Under the Ticker “NM”

Novamind Receives CSE Conditional Listing Approval Under the Ticker “NM”

  • Post published:December 22, 2020
  • Post category:Press Release
Novamind Closes Oversubscribed CAD$10 Million Private Placement

Novamind Closes Oversubscribed CAD$10 Million Private Placement

  • Post published:November 23, 2020
  • Post category:Press Release
Novamind and Hinterland Metals Enter into Amalgamation Agreement

Novamind and Hinterland Metals Enter into Amalgamation Agreement

  • Post published:November 17, 2020
  • Post category:Press Release
Novamind Sponsors TheraPsil, an Advocate for the Compassionate Use of Psilocybin in Canada

Novamind Sponsors TheraPsil, an Advocate for the Compassionate Use of Psilocybin in Canada

  • Post published:July 31, 2020
  • Post category:Press Release
Novamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S.

Novamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S.

  • Post published:July 30, 2020
  • Post category:Press Release
Novamind Announces Closing of Oversubscribed Private Placement

Novamind Announces Closing of Oversubscribed Private Placement

  • Post published:July 14, 2020
  • Post category:Press Release

End of content

No more pages to load

Older Posts →

Psilocybin Alpha

The definitive resource for investors in the emergent psychedelic medicine sector. Cut through the shroom stock noise with exclusive news, interviews, data and private financing opportunities.

Quick Links

  • Psychedelic Stocks and Companies
  • News & Interviews
  • Psychedelic Sector Jobs
  • Data Bank

Newsletter

Industry insights and interviews delivered to your inbox. No spam, just valuable information.

Psilocybin Alpha Logo Small
  • Psilocybin Alpha © 2021, All Rights Reserved
  • Privacy Policy
  • Terms of Service